Label-Free Detection of Molecular Interactions

161308-Thumbnail Image.png
Description
Quantifying molecular interactions is critical to the understanding of many biological processes and drug screening. To date, various detection techniques have been developed to determine the binding kinetics. However, because most of the mainstream detection technologies detect signals that scale

Quantifying molecular interactions is critical to the understanding of many biological processes and drug screening. To date, various detection techniques have been developed to determine the binding kinetics. However, because most of the mainstream detection technologies detect signals that scale with the mass of ligands bond to the sensor surface, it is still challenging to quantify the binding kinetics of small molecules. To address this problem, two different detection technologies, charge-sensitive optical detection (CSOD) and critical angle reflection (CAR), are developed for label-free detection of molecular interactions with the ability to detect a wide range of molecules including small molecules. In particular, CSOD technique detects the charge rather than the mass of a molecule with an optical fiber. However, the effective charge of a molecule decreases with the buffer ionic strength. For this reason, the previous CSOD works with diluted buffers, which could affect the measured molecular binding kinetics. Here a technique capable of detecting molecular binding kinetics in normal ionic strength buffers is presented. An H-shaped sample well was developed to overcome this problem. With this new design, the binding kinetics between G-protein-coupled receptors (GPCRs) and their small molecule ligands were measured in normal buffer. To further improve the signal-to-noise ratio of CSOD and move it toward high-throughput detection, CSOD was implemented with a quadrant-cell detector to achieve detection in higher frequency range and decrease low-frequency noise.This improved CSOD technique is capable for direct quantification of binding kinetics of phage-displayed peptides to their target protein using the whole phages. CAR imaging can be performed on surface plasmon resonance (SPR) imaging setups. It was shown that CAR is capable of measuring molecular interactions including proteins, nucleic acids and cell-based detections. In addition, it was shown that CAR can detect small molecule bindings and intracellular signals beyond SPR sensing limit. CAR exhibits several distinct characteristics over SPR, including tunable sensitivity and dynamic range, deeper vertical sensing range, and fluorescence compatibility. CAR is anticipated to have the ability to expand SPR capability in small molecule detection, whole cell-based detection, simultaneous fluorescence imaging, and broader conjugation chemistry.
Date Created
2021
Agent

Label Free Methods for the Quantification of Molecular Interaction with Membrane Protein on Cell Surface

156784-Thumbnail Image.png
Description
Measuring molecular interaction with membrane proteins is critical for understanding cellular functions, validating biomarkers and screening drugs. Despite the importance, developing such a capability has been a difficult challenge, especially for small molecules binding to membrane proteins in their native

Measuring molecular interaction with membrane proteins is critical for understanding cellular functions, validating biomarkers and screening drugs. Despite the importance, developing such a capability has been a difficult challenge, especially for small molecules binding to membrane proteins in their native cellular environment. The current mainstream practice is to isolate membrane proteins from the cell membranes, which is difficult and often lead to the loss of their native structures and functions. In this thesis, novel detection methods for in situ quantification of molecular interactions with membrane proteins are described.

First, a label-free surface plasmon resonance imaging (SPRi) platform is developed for the in situ detection of the molecular interactions between membrane protein drug target and its specific antibody drug molecule on cell surface. With this method, the binding kinetics of the drug-target interaction is quantified for drug evaluation and the receptor density on the cell surface is also determined.

Second, a label-free mechanically amplification detection method coupled with a microfluidic device is developed for the detection of both large and small molecules on single cells. Using this method, four major types of transmembrane proteins, including glycoproteins, ion channels, G-protein coupled receptors (GPCRs) and tyrosine kinase receptors on single whole cells are studied with their specific drug molecules. The basic principle of this method is established by developing a thermodynamic model to express the binding-induced nanometer-scale cellular deformation in terms of membrane protein density and cellular mechanical properties. Experiments are carried out to validate the model.

Last, by tracking the cell membrane edge deformation, molecular binding induced downstream event – granule exocytosis is measured with a dual-optical imaging system. Using this method, the single granule exocytosis events in single cells are monitored and the temporal-spatial distribution of the granule fusion-induced cell membrane deformation are mapped. Different patterns of granule release are resolved, including multiple release events occurring close in time and position. The label-free cell membrane deformation tracking method was validated with the simultaneous fluorescence recording. And the simultaneous cell membrane deformation detection and fluorescence recording allow the study of the propagation of the granule release-induced membrane deformation along cell surfaces.
Date Created
2018
Agent